Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,541 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Resmetirom for nonalcoholic steatohepatitis.
Fahim SM, Tice JA, Suh K, Carlson JJ, Richardson M, Chu JN, Herce-Hagiwara B, Agboola F, Rind D, Pearson SD. Fahim SM, et al. Among authors: suh k. J Manag Care Spec Pharm. 2023 Oct;29(10):1169-1172. doi: 10.18553/jmcp.2023.29.10.1169. J Manag Care Spec Pharm. 2023. PMID: 37776115 Free PMC article. No abstract available.
The potential long-term comparative effectiveness of larotrectinib vs standard of care for treatment of metastatic TRK fusion thyroid cancer, colorectal cancer, and soft tissue sarcoma.
Suh K, Carlson JJ, Xia F, Williamson T, Sullivan SD. Suh K, et al. J Manag Care Spec Pharm. 2022 Jun;28(6):622-630. doi: 10.18553/jmcp.2022.21373. Epub 2022 Apr 1. J Manag Care Spec Pharm. 2022. PMID: 35362337
Given the limitations of this analytic approach and the small sample size for larotrectinib in trials, future studies should reassess the comparative effectiveness of larotrectinib vs standard of care as treated patients accrue and long-term survival data mature. DISCLOSURES: …
Given the limitations of this analytic approach and the small sample size for larotrectinib in trials, future studies should reassess the co …
The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory Council.
Nikitin D, Makam AN, Suh K, McKenna A, Carlson JJ, Richardson M, Rind DM, Pearson SD. Nikitin D, et al. Among authors: suh k. J Manag Care Spec Pharm. 2023 Feb;29(2):216-221. doi: 10.18553/jmcp.2023.29.2.216. J Manag Care Spec Pharm. 2023. PMID: 36705279 Free PMC article.
Atidarsagene autotemcel for metachromatic leukodystrophy.
Fahim SM, Lin G, Suh K, Carlson JJ, Richardson M, Herce-Hagiwara B, Dickerson R, Pearson SD, Rind DM, Agboola F. Fahim SM, et al. Among authors: suh k. J Manag Care Spec Pharm. 2024 Feb 3;30(2):201-205. doi: 10.18553/jmcp.2024.30.2.201. J Manag Care Spec Pharm. 2024. PMID: 38308621 Free PMC article. No abstract available.
1,541 results